Filing Details

Accession Number:
0001209191-19-049864
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-09-17 16:46:28
Reporting Period:
2019-09-13
Accepted Time:
2019-09-17 16:46:28
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1582313 Xenon Pharmaceuticals Inc. XENE () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1309653 Mohammad Azab 200 - 3650 Gilmore Way
Burnaby A1
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Shares Disposition 2019-09-13 23 $9.31 57,561 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Shares Stock Option (Right to Buy) Acquisiton 2019-09-16 15,000 $0.00 15,000 $9.44
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
15,000 2029-09-15 No 4 A Direct
Footnotes
  1. One-third of the total shares subject to the Option shall vest on the one year anniversary of the grant date, one-third of the total shares subject to the Option shall vest on the two year anniversary of the grant date, one-third of the total shares subject to the Option shall vest on the three year anniversary of the grant date.